Patient-based drug discovery's latest news
Meet us in Boston!
We believe better drugs start with better translational models! Curious to know more about how we combine complex patient-based cellular disease models with AI-enhanced...
Meet us in Basel!
This year, Ksilink will be present at several key partnering and business conferences. Curious about our cutting-edge work in disease modeling, AI-driven image analysis for assay...
We are thrilled to announce the arrival of our new Chief Operating Officer!
Dr Helmut Haning has recently joined the management of Ksilink as COO, complementing the team with a longstanding experience in pharmaceutical drug discovery. He brings to the...
Join Ksilink at BIO Partnering @ JPM Week 2025!
We are excited to announce that Mona Boyé, Head of BD & Partnerships, and Johannes Wilbertz, Team Leader Neuroscience, will be attending BIO Partnering @ JPM Week in San...
Ksilink Advances PMDS Research and Disease Modelling
Strasbourg, France – Ksilink, together with our collaborators from I-Stem (Paris), has recently published a scientific paper that provides significant insights into...
02.04.2024: World Autism Awareness Day
Link to photo source (UN) At Ksilink, it is one of our core missions to develop new therapeutic modalities to treat autism and particularly a rare form called Phelan McDermid...
New Study on the Impact of Endocrine Disrupting Chemicals on Parkinson’s Disease
New Study on the Impact of Endocrine Disrupting Chemicals on Parkinson’s Disease Ksilink, in collaboration with researchers from the University of Chieti in Italy, has published...
Review Article in JAMA Psychiatry
Schumann G, Andreassen OA, Banaschewski T, et al. Addressing Global Environmental Challenges to Mental Health Using Population Neuroscience: A Review. JAMA Psychiatry....
Press Release of the IMPACT consortium, engaged in finding novel therapies to fight Arrhythmogenic Cardiomyopathy
Thanks to the funding obtained from Horizon Europe, this research project aims to open up new therapeutic perspectives based on the results obtained from various disease models....
